Epidemiological and clinical characteristics of central nervous system infections in a tertiary center: A retrospective study

Abstract

Background and Aims Central nervous system (CNS) infection is one of the most common causes of morbidity, mortality, and hospital admission worldwide. The natural history of CNS infection is quite fatal. Early diagnosis and treatment have been proven to have a crucial role in patients' survival. The aim of this study was to identify the epidemiological and clinical patterns of patients diagnosed with CNS infections. Methods This study is a retrospective study conducted in a tertiary level hospital in Nepal in which patient diagnosed with CNS infections (September 2019 to 2021) were included. Data were collected and analyzed in SPSS. Results The mean age of the 95 patients included in the study was 45.18 ± 19.56. Meningoencephalitis ( n = 44, 46.30%) was the most common infection diagnosed. Patients belonging to the age group 30−60 years had a higher frequency of focal neurological deficit, and other classical clinical features. All the patients who died during the treatment had associated comorbidities but no concurrent infections. Altered sensorium, fever, and headache were the common presenting symptoms in all the recovered patients. Conclusion To ensure optimum disease outcome, early diagnosis and prompt management are crucial. For this, recognizing the local disease patterns in terms of disease distribution, commonly implicated aetiologies, presenting symptoms, and prognostic factors is of utmost importance.

Plausible use of citicoline as an adjuvant in central nervous system infections: A case report and review of the literature

“…These infections typically present with typical signs, such as fever, headache and vomiting. They can progress to more severe symptoms, including seizures, altered consciousness, neurological deficits, sensory disturbances and visual impairment (3)(4)(5). From 1990 to 2016, there were an estimated 389 cases of CNS infections per 100,000 individuals worldwide, with a higher incidence in low-and middle-income countries compared to high-income countries, particularly Southeast Asia (3).…”